03.09.2024 • News

Evonik Completes Expansion of Methionine Production in Singapore

Evonik has completed the expansion of its MetAmino (DL-methionine) production facilities in Singapore and the production on Jurong Island is again running at full capacity, after shutdowns in the fourth quarter of 2023 and the second quarter of 2024.

The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year, the company said.

According to Evonik, it has optimized its methionine production plants through process intensification, generating a surplus of steam that is used to produce on-site electricity.

Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a 9-MW alkaline electrolyzer plant at the site that enables Evonik to use green hydrogen required for the MetAmino production, thus reducing its environmental impact.

“Our collaboration with Linde on the implementation of green hydrogen in our Singapore facilities is a testament to our commitment to sustainability. We work closely with our partners to build a more sustainable future," commented Harald Schwager, deputy chairman of Evonik’s executive board.

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of MetAmino at this site by 6% compared to before the expansion, the company stated.

Gaetano Blanda, head of Evonik’s Animal Nutrition business line, said: “We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway, and reach net-zero emissions by 2050.”

MetAmino is used in livestock farming for feeding animals.

© RubyMirriam/Getty Images
© RubyMirriam/Getty Images

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.